'Bone Up'
SABRE: A New Era for Osteoporosis Trials
49:09
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
The lads sit down with Mary Bouxsein to explore SABRE — the landmark project aiming to make BMD a validated regulatory endpoint in osteoporosis trials. Mary walks us through how her team brought together data from more than 160,000 patients, why this could transform the speed and ethics of…